Dendreon
Dendreon is a California-based biopharmaceutical company that develops and commercializes novel based immuno-therapeutics for the treatment of cancer.
Business Model:
Revenue: $312M
Employees: 501-1,000
Rankings
Industries / Tags:
Detailed Dendreon Information
Dendreon was acquired by
Sanpower Group.
The acquisition happend on 2017-06-29.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1700 Saturn Way
City: Seal Beach
State: CA
Zip: 90740
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$90M
Social
Metrics
4,930,936Website Global Rank
2,049Website Monthly Traffic
Twitter Followers
Description
Dendreon is a California-based biopharmaceutical company that develops and commercializes novel based immuno-therapeutics for the treatment of cancer.
Contact Phone:
+18772564545
Contact Email:
Dendreon went public on 6/23/2000 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/23/2000
Ticker Symbol:
DNDN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2003 | Corvas International, Inc. |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
